Skip to main content
# Title Research Year
61 Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) 2017
62 Noninvasive biomarkers as surrogate predictors of clinical
and endoscopic remission after infliximab induction in
patients with refractory ulcerative colitis
2017
63 Types and microbiological spectrum of infections in patients
with cirrhosis: A single-centre experience in Upper Egypt
2017
64 Prevalence of Occult HBV Infection Among Chronic Hepatitis C Patients in Upper Egypt 2017
65 Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) 2017
66 Noninvasive biomarkers as surrogate predictors of clinical
and endoscopic remission after infliximab induction in
patients with refractory ulcerative colitis
2017
67 Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) 2017
68 Latent tuberculosis infection among patients with erectile dysfunction 2017
69 Prevalence of occult hepatitis C virus in patients with HCV - antibody positivity and serum HCV RNA negativity 2016
70 A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis. 2016